Skip to content

    Tube Investments

    TIINDIA
    Automobile and Auto Components·13 May 2026
    Management Summary

    Tube Investments delivered strong Q4 FY26 results with double-digit revenue growth across standalone and consolidated entities. The company is optimistic about its TI Medical business and has successfully addressed key supply chain bottlenecks in its 3-wheeler EV segment, anticipating a return to full production. However, some segments like Metal Formed Products and subsidiary Shanthi Gears showed muted performance, and the EV business continues to navigate deployment challenges related to financing and infrastructure.

    Highlights

    5
    • Standalone Q4 revenue increased 16.4% YoY to ₹2,279 crores, with full-year revenue up 8.4% YoY to ₹8,556 crores.

    • Consolidated Q4 revenue grew 20.7% YoY to ₹6,215 crores, and full-year consolidated revenue rose 17.4% YoY to ₹22,847 crores.

    • Standalone Q4 PBT before exceptional items and fair value gain on CCPS was ₹361 crores, a 10.4% YoY increase.

    • TI Medical business is confident of 15-20% year-on-year growth, supported by a recent acquisition and plant approvals.

    • The critical body-in-white supply issue for the 3-wheeler EV segment has been resolved, with normal production capacity expected in Q1 FY27.

    Concerns

    4
    • Metal Formed Products segment showed sluggish growth, with Q4 revenue up only 4.5% YoY and PBIT declining 10.3% YoY to ₹35 crores.

    • Shanthi Gears Limited, a subsidiary, reported a Q4 revenue decline of 11.8% YoY to ₹135 crores and PBT drop of 19.4% YoY to ₹25 crores.

    • EV deployment faces significant challenges related to financing (₹100 crores for 50-100 trucks) and charging infrastructure.

    • The medical devices business experienced headwinds in the Middle East due to the war scenario, impacting exports.

    Key financials

    Single quarter

    06 metrics
    1. 01Standalone Revenue₹2,279 Cr+16.4%YoY
    2. 02Standalone PBT (excl. exceptional)₹361 Cr+10.4%YoY
    3. 03Standalone FY26 Revenue₹8,556 Cr+8.4%YoY
    4. 04Consolidated Revenue₹6,215 Cr+20.7%YoY
    5. 05Consolidated FY26 Revenue₹22,847 Cr+17.4%YoY

    Segment breakdown

    Q4 RevenueFY RevenueQ4 PBITFY PBIT
    Engineering₹1,495 Cr₹5,612 Cr₹176 Cr₹689 Cr
    Metal Formed Products₹421 Cr₹1,603 Cr₹35 Cr₹162 Cr
    Mobility₹208 Cr₹783 Cr₹4 Cr₹19 Cr
    Other businesses₹246 Cr₹923 Cr₹16 Cr₹70 Cr
    CG Power and Industrial Solutions Limited
    Shanthi Gears Limited₹135 Cr₹519 Cr
    Heatmap· 4 shared metrics

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹600 crores

    Dividend

    ₹1.5/share (final)

    M&A

    Medicura facility (IV cannula business)

    acquisition · closed

    Guidance & targets

    7
    CategoryTargetPriority
    Other
    TI Medical YoY Growth
    15% to 20%
    High
    Other
    3-Wheeler Body-in-White Supply Resolution
    resolved
    High
    Capex
    Core Business Capex
    Rs.300 Crores to Rs.350 Crores
    High
    Capex
    Subsidiaries Capex
    Rs.300 Crores
    High
    Capacity
    CDMO Commercial Production Start
    starting next quarter
    High
    Capacity
    CRSS Plant Utilization
    100% utilized
    Medium
    Capacity
    Western Region Tube Facilities Utilization
    100% utilized
    Medium

    CDMO Commercial Production Start

    Next quarter (Q1 FY27)
    CurrentUnder final commissioning
    TargetCommercial production started

    Why it matters

    Marks the revenue commencement for a new strategic business, crucial for diversification and future growth.

    And we are going to do the commercial production from our Naidupet facility starting next quarter.

    How to verify

    capital_allocation.capex.purposes[description='CDMO facility']

    Risks & concerns

    5
    RiskSeverity

    Challenging macro environment, commodity price increases, and fuel prices.

    Macroeconomic conditions and rising input costs, particularly fuel, pose challenges, though commodity price increases are recoverable with a lag due to existing contracts.Other acknowledged

    medium

    Delays in railway business scale-up due to government approvals.

    The scale-up of the railway business is delayed as product approval with the Government of India for Vande Bharat coaches is still in progress.Other acknowledged

    medium

    EV deployment challenges (financing and charging infrastructure).

    Significant capital (₹100 crores for 50-100 trucks) is required for EV deployment, and the lack of adequate charging infrastructure poses a key hurdle for scaling up EV volumes.Other acknowledged

    high

    Headwinds in Medical Devices exports (Middle East).

    The war scenario has temporarily impacted the Middle East business, which was previously a good market for medical devices exports.Other acknowledged

    low

    Sluggish performance in Metal Formed Products (MFPD).

    MFPD's performance was impacted by profitability issues in the railway tender business and muted growth from a major OEM customer, Hyundai, though improvement is expected with new Western plant operations.Other acknowledged

    medium

    Q&A highlights

    8

    “So, it is almost in line, because there are no major price movements in the Q4. So, you can consider whatever is the sales growth shown in the Q4, it is in line with the volume growth.”

    Clarifies that the strong revenue growth in the engineering segment is primarily driven by volume, not price increases.

    asked by Joseph George

    3 min read6 chapters

    Detailed Narrative

    01

    Q4 FY26 Performance Overview

    Tube Investments delivered a strong Q4 FY26, with standalone revenue increasing 16.4% year-on-year to ₹2,279 crores and full-year revenue reaching ₹8,556 crores, an 8.4% YoY growth. Standalone PBT before exceptional item📎s and fair value gain on CCPS for Q4 stood at ₹361 crores, up 10.4% YoY, while the full-year PBT was ₹1,099 crores, a 12.7% increase. Consolidated revenue for Q4 grew 20.7% YoY to ₹6,215 crores, and for the full year, it was ₹22,847 crores, up 17.4% YoY. The company maintained a robust ROIC of 44% for the year and generated ₹826 crores in cumulative free cash flow, representing 100% of PAT.

    02

    Segmental Business Performance

    The Engineering segment was a key growth driver, with Q4 revenue up 21.6% YoY to ₹1,495 crores and PBIT up 23.9% YoY to ₹176 crores. The Mobility business also saw Q4 revenue growth of 14.9% YoY to ₹208 crores, though PBIT remained flat at ₹4 crores. In contrast, the Metal Formed Products segment experienced sluggish growth, with Q4 revenue up only 4.5% YoY to ₹421 crores and PBIT declining 10.3% YoY to ₹35 crores, attributed to railway profitability issues and muted demand from a key OEM. Other businesses showed marginal Q4 revenue growth of 0.8% to ₹246 crores, with PBIT increasing 23.1% to ₹16 crores.

    03

    Subsidiary Performance

    CG Power and Industrial Solutions Limited, a 56% owned subsidiary, delivered strong results with Q4 consolidated revenue growing 25.0% YoY to ₹3,442 crores and PBT before exceptional item📎s up 27.6% YoY to ₹490 crores. For the full year, CG Power's revenue increased 25.3% YoY to ₹12,418 crores. However, Shanthi Gears Limited, a 70% owned subsidiary, faced challenges, reporting a Q4 revenue decline of 11.8% YoY to ₹135 crores and a PBT drop of 19.4% YoY to ₹25 crores. Its full-year revenue also decreased by 14.2% YoY to ₹519 crores.

    04

    Electric Vehicle Business Update

    The EV segment is experiencing an 'upswing in demand,' particularly in heavy truck and small commercial vehicle segments, with a 'very good order book' for big trucks. However, deployment challenges persist, primarily due to financing requirements (₹100 crores for 50-100 trucks) and the need for robust charging infrastructure. For 3-wheelers, a critical body-in-white supply issue, which impacted Q4 volumes (producing only 50% of potential), has been resolved, and the company expects to return to normal production capacity in Q1 FY27. The company is also actively pursuing cost reduction and localization across all EV platforms, having achieved PM E-drive certification for its Montra Electric Rhino in Q4.

    05

    Medical Devices & CDMO Business

    The TI Medical business is projected to grow by 15-20% year-on-year, supported by a recent asset acquisition of the Medicura facility in Ambala for the IV cannula business, which is expected to commence operations after plant approvals in Q1/Q2 FY27. While the business faced temporary headwind📎s in the Middle East due to geopolitical situations, the company remains bullish on its growth prospects. The CDMO business is nearing completion of its Naidupet facility, with commercial production anticipated to begin in the next quarter (Q1 FY27), marking a new revenue stream.

    06

    Capital Expenditure Plans

    For the upcoming fiscal year (FY27), Tube Investments plans a capital expenditure of approximately ₹300-350 crores for its core businesses. Additionally, an estimated ₹300 crores will be invested in its subsidiaries, including the EV business and TI Medical. These investments are aimed at supporting growth initiatives, capacity expansion, and the operationalization of new ventures like the CDMO facility and the acquired IV cannula business. The company also anticipates 100% utilization of its CRSS plant in Nasik and Western region Tube facilities by the end of FY27 or mid-FY28.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.